S03 E04
Surgibots Podcast

The Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens - Caresyntax

Explore the complexity of clinical data with Bjoern von Siemens, the Founder of Caresyntax and this week’s guest speaker. In this episode, hosted by Henry Norton, Bjoern discussed the future of MedTech, including the role that data and AI will play in developing the technology that is currently set to transform surgery for future generations. They also touched on the importance of reducing the cost of care and making safe surgery accessible to everyone. Tune in to learn more about the role of automation and analytics in developing the surgical robotics industry.

The Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens - Caresyntax

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
S04 E04

The Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens - Caresyntax

 

The Future of Surgical Robotics: Insights from Bjoern von Siemens

Surgical Robotics and Data Integration: A New Era of Precision Medicine

The intersection of surgical robotics, AI, and data aggregation is shaping the future of medtech. In a recent Surgibots podcast episode, Bjoern von Siemens, co-founder of CareSyntax, shared his insights on how data-driven technologies are transforming surgery and why precision medicine is the future of healthcare.

The Competitive Landscape in Surgical Robotics

One of the most striking takeaways from the conversation was Siemens’ assertion that the biggest competition in surgical robotics may not necessarily be another robotics company—but rather those who aggregate and utilize surgical data effectively.

"Companies best positioned to capture clinical information—data on patients and the entire episode of care—will ultimately be able to create the most effective therapies and devices," Siemens explained.

This highlights a shift in competition: from just developing advanced robotic systems to owning and leveraging high-fidelity surgical data.

The Role of AI in Surgical Innovation

CareSyntax has been at the forefront of integrating AI into surgical workflows. Siemens shared that when the company was founded over a decade ago, AI in surgery was met with skepticism. Today, AI-driven automation is increasingly recognized as essential to optimizing surgical processes.

Early applications of AI in surgery have included:

  • Automating operating room setup
  • Providing real-time surgical insights
  • Predicting post-operative complications
  • Enhancing workflow efficiency with predictive analytics

The ability to reduce risk factors and improve patient outcomes through AI is now a critical driver for hospitals and medtech companies alike.

Overcoming Challenges in Surgical Automation

While the benefits of automation in surgery are clear, Siemens pointed out key roadblocks to its widespread adoption:

  • Financial Barriers: Many hospitals struggle to secure funding for new technologies, with limited reimbursement models available for AI-driven surgical assistance.
  • Regulatory Challenges: AI-driven decision-making must be rigorously tested and validated before it can be widely implemented.
  • Cultural Adoption: Many healthcare professionals have been burned by inefficient digital solutions in the past, leading to skepticism about new technologies.
  • Competitive Dynamics: Medtech incumbents may resist changes that disrupt traditional device sales models.

Overcoming these challenges requires a combination of better funding models, stronger regulatory frameworks, and clearer evidence of improved surgical outcomes.

The Future of Surgical Robotics

Looking ahead, Siemens envisions a future where digital workflows and AI-powered guidance become essential components of every surgical procedure. Some key predictions include:

  • Mass Adoption of Surgical Robotics: As technology advances and costs decline, robotic-assisted surgery will become the norm across multiple disciplines.
  • Increased Focus on Digital Platforms: Robotics will no longer be just about hardware—successful systems will integrate software solutions that provide real-time guidance and optimize workflows.
  • More Accessible Surgery: While today’s robotic platforms are largely confined to premium markets, future iterations—especially from emerging markets like China and India—will make surgical robotics more affordable and globally available.
  • The Role of Data Aggregators: Companies like CareSyntax are poised to play a crucial role in transforming surgical outcomes by providing AI-driven insights based on high-fidelity surgical data.

Final Thoughts

The medtech landscape is rapidly evolving, and surgical robotics is at the forefront of this transformation. As AI and data-driven insights become more deeply integrated into surgical procedures, the next decade will likely see unprecedented advancements in precision medicine and patient outcomes.

CareSyntax is positioning itself as a key enabler in this space, ensuring that the right technologies are deployed to create safer, more efficient, and more personalized surgical care.

For those interested in the latest developments in surgical robotics and medtech innovation, the Surgibots podcast provides invaluable insights from industry pioneers shaping the future of healthcare.

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental
Podcast41

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental

Join host Henry Norton in this episode of The Crux of Medtech as he speaks to Paul Roberts, co-founder of CMR Surgical and current CEO of Lupin Dental. Paul shares the journey from building surgical robots in a former pig shed to co-founding one of the most recognised names in robotic surgery. Now, he’s applying that experience to an entirely new frontier, aesthetic dental robotics. In this episode, Paul explains why dental veneers are about more than vanity, how robotic precision can eliminate outdated practices like tooth stumping, and why Lupin’s tech could completely transform smile restoration. He also opens up about his medtech philosophy, including why engineers shouldn’t build products alone, and what it really takes to move from zero to launch in a capital-intensive field like robotics. Key Topics Why Paul left surgical robotics for dental robotics The founding story of CMR Surgical The clinical and aesthetic importance of veneers How Lupin reduces a 5-visit dental process into 1 What medtech can learn from AlignTech and Invisalign Building a profitable robot company without hundreds of millions Related Insights Crowns are outdated. Robotic veneers restore enamel with less damage Engineers alone don’t make great products clinicians must co-create One robotic session at Lupin replaces five traditional dental visits India is a strategic first market and a smart regulatory play Fail fast, but never compromise on patient safety Core Challenges Tooth restoration has long been inefficient: dentists rely on hand-guesswork for shaping and prepping teeth. It’s a manual, error-prone process that requires multiple appointments and can cause long-term sensitivity. Lupin Dental solves this with AI-powered planning, CAD design, and a precision robot that prepares the tooth and bonds the veneer all in one session. Tune in now to hear how surgical-grade robotics are reshaping the smile economy and why Lupin Dental could be the next CMR.
Artificial Intelligence Feels Like Magic - With Peter Verrillo
Podcast40

Artificial Intelligence Feels Like Magic - With Peter Verrillo

Meet Peter Verrillo, the CEO of Redefine Surgery. He joins your host, Henry Norton, in this episode to discuss the latest developments in orthopaedic AI. Throughout the conversation, Peter highlights how time-consuming knee surgery can be, and talks about the AI solutions that his company is creating to reduce the time spent in theatre. Peter also shares his journey as a founder of multiple different companies, touching on everything from funding and acquisitions to building prototypes in his basement. He also emphasises the benefits of working with device-manufacturing companies, as they will take his AI to market under a whitelabel. He states that this relationship is a key part of the medtech industry. Peter also touches on the importance of strong sales reps, suggesting that they should have training in both the software and robotics sides of this new technology in order to efficiently translate it to surgeons.

Discover more about Medical Devices